The human heart’s rhythmic beat is more than a life-sustaining pump—it may be one of the body’s most effective natural defenses against malignancy. For decades, the medical community has noted that primary heart cancer is vanishingly rare, but the “why” remained a mystery. New research published in Science suggests that the answer isn’t just chemical … Read more
The Beat That Defeats Cancer: Unlocking the Secrets of Heart Cancer Rarity The human heart is far more than a biological pump; it is a fortress. While cancer ravages almost every other organ system in the body, the heart remains remarkably resistant to primary tumors. For decades, this was a medical mystery, but emerging research … Read more
In a landmark decision offering hope to families facing a devastatingly rare condition, the Food and Drug Administration (FDA) has granted approval for Kresladi, a groundbreaking gene therapy designed to treat severe leukocyte adhesion deficiency type 1 (LAD-1). The approval, announced Thursday, marks a significant step forward in the field of genetic medicine and provides … Read more
The Urgent Need for FDA Flexibility in Rare Disease Treatment Washington D.C. – A growing chorus of patient advocates and medical experts are calling on the Food and Drug Administration (FDA) to more readily embrace flexible regulatory pathways for therapies targeting rare diseases. With existing frameworks already granting the agency discretion in evaluating these treatments, … Read more